Tuftsin-phosphorylcholine treatment of autoimmune diseases - a benefit and a message from helminths?
Reumatologia
.
2017;55(6):267-268.
doi: 10.5114/reum.2017.72622.
Epub 2017 Dec 30.
Authors
Maria Maślińska
1
,
Fabrizio de Luca
2
,
Kassem Sharif
3
4
5
Affiliations
1
Early Arthritis Clinic National Institute of Geriatrics, Rheumatology, and Rehabilitation, Warsaw, Poland.
2
School of Medicine, Milan University, Department of Allergy and Immunology, Niguarda Ca' Granda Metropolitan Hospital, Milan, Italy.
3
Internal Medicine B, Sheba Medical Centre, Tel-Hashomer, Israel.
4
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Centre, Tel-Hashomer, Israel.
5
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
PMID:
29491533
PMCID:
PMC5825963
DOI:
10.5114/reum.2017.72622
No abstract available
Publication types
Editorial